Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17718
Country/Region: Kenya
Year: 2016
Main Partner: IMA World Health
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: USAID
Total Funding: $8,134,682 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,561,098
Care: TB/HIV (HVTB) $675,070
Care: Pediatric Care and Support (PDCS) $211,304
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $37,827
Sexual Prevention: Abstinence/Be Faithful (HVAB) $786,906
Testing: HIV Testing and Counseling (HVCT) $561,382
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $708,761
Treatment: Adult Treatment (HTXS) $3,495,895
Treatment: Pediatric Treatment (PDTX) $96,439
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: 10-14 Female 2017 240
GEND_GBV Age/Sex: 15-19 Female 2017 450
GEND_GBV Age/Sex: 20-24 Female 2017 450
GEND_GBV Number of people receiving post-GBV care 2017 1,141
GEND_GBV Sum of Age/Sex Disaggregates 2017 240
HTS_TST Age/sex: <1 2017 874
HTS_TST Age/sex: 1-9 2017 1,231
HTS_TST Age/sex: 10-14 Female 2017 1,338
HTS_TST Age/sex: 10-14 Male 2017 700
HTS_TST Age/sex: 15-19 Female 2017 21,017
HTS_TST Age/sex: 15-19 Male 2017 12,384
HTS_TST Age/sex: 20-24 Female 2017 40,830
HTS_TST Age/sex: 20-24 Male 2017 24,751
HTS_TST Age/sex: 25-49 Female 2017 46,208
HTS_TST Age/sex: 25-49 Male 2017 28,886
HTS_TST Age/sex: 50+ Female 2017 26,424
HTS_TST Age/sex: 50+ Male 2017 16,508
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 2,445
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,754
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 134,221
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 82,731
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 221,151
HTS_TST Service Delivery Point (Community): Other 2017 3,044
HTS_TST Service Delivery Point (Facility): Index testing 2017 89
HTS_TST Service Delivery Point (Facility): Inpatient 2017 33,404
HTS_TST Service Delivery Point (Facility): Outpatient 2017 49,818
HTS_TST Service Delivery Point (Facility): PMTCT 2017 50,796
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 19,318
HTS_TST Service Delivery Point (Facility): VCT 2017 61,936
HTS_TST Service Delivery Point (Facility): VMMC 2017 2,746
HTS_TST Sum of Age/Sex disaggregates 2017 219,046
HTS_TST Sum of Aggregated Age/Sex <15 2017 4,199
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 216,952
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 221,151
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 101
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 99
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 707
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 707
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 1,399
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 1,397
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 1,684
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 1,672
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 938
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 944
HTS_TST_POS Test Result by Age: Positive: <1 2017 121
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 164
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 366
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 360
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 4,597
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 4,610
OVC_SERV Age/Sex: 18+ Female 2017 405
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 1,107
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 1,680
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 15-17 2017 330
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 18-24 2017 333
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2017 160
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2017 977
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 18-24 2017 153
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 10-14 2017 797
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 15-17 2017 1,353
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 18-24 2017 1,353
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 10-14 2017 143
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 15-17 2017 653
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 18-24 2017 722
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2017 330
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 18-24 2017 1,133
OVC_SERV Sum of Age/Sex disaggregates 2017 405
PMTCT_ART Already on ART at beginning of current pregnancy 2017 915
PMTCT_ART New on ART 2017 616
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 53,076
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 1,520
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 267
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 25
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 46
PMTCT_EID Sum of Infant Age disaggregates 2017 1,787
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 113
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 6,271
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 18,992
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 16,621
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 11,079
PMTCT_STAT By: Known positives at entry 2017 1,062
PMTCT_STAT By: Number of new positives identified 2017 456
PMTCT_STAT Number of new ANC and L&D clients 2017 53,076
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 53,076
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 527
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 531
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 459
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,518
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 113
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 6,271
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 18,992
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 16,621
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 11,079
PrEP_NEW Female 15-19 2017 115
PrEP_NEW Female 20-24 2017 488
PrEP_NEW Number of individuals who have received antiretroviral preexposure 2017 603
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 76
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1,434
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 76
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1,434
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 3,020
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 3,020
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 19,878
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 19,878
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 1,074
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 1,074
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 41,904
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 173
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3,252
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 173
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3,252
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 6,850
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 6,850
TX_CURR Age/Sex: <1 2017 330
TX_CURR Age/Sex: <1-9 2017 778
TX_CURR Age/Sex: 10-14 Female 2017 1,053
TX_CURR Age/Sex: 10-14 Male 2017 1,053
TX_CURR Age/Sex: 15-19 Female 2017 4,045
TX_CURR Age/Sex: 15-19 Male 2017 4,045
TX_CURR Age/Sex: 20-24 Female 2017 5,068
TX_CURR Age/Sex: 20-24 Male 2017 5,068
TX_CURR Age/Sex: 25-49 Female 2017 6,080
TX_CURR Age/Sex: 25-49 Male 2017 6,080
TX_CURR Age/Sex: 50+ Female 2017 5,058
TX_CURR Age/Sex: 50+ Male 2017 5,058
TX_CURR Aggregated Age/Sex: <15 Female 2017 1,615
TX_CURR Aggregated Age/Sex: <15 Male 2017 1,615
TX_CURR Aggregated Age/Sex: 15+ Female 2017 20,243
TX_CURR Aggregated Age/Sex: 15+ Male 2017 20,243
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 43,716
TX_CURR Sum of age/sex disaggregates 2017 8,090
TX_CURR Sum of Aggregated Age/Sex <15 2017 3,230
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 40,486
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 43,716
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 169
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 169
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 4,356
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 4,374
TX_NEW By Age/Sex: <1 2017 46
TX_NEW By Age/Sex: 1-9 2017 68
TX_NEW By Age/Sex: 10-14 Female 2017 106
TX_NEW By Age/Sex: 10-14 Male 2017 106
TX_NEW By Age/Sex: 15-19 Female 2017 870
TX_NEW By Age/Sex: 15-19 Male 2017 870
TX_NEW By Age/Sex: 20-24 Female 2017 1,076
TX_NEW By Age/Sex: 20-24 Male 2017 1,095
TX_NEW By Age/Sex: 25-49 Female 2017 1,318
TX_NEW By Age/Sex: 25-49 Male 2017 1,318
TX_NEW By Age/Sex: 50+ Female 2017 1,096
TX_NEW By Age/Sex: 50+ Male 2017 1,099
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 9,068
TX_NEW Sum of Age/Sex disaggregates 2017 8,954
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 9,068
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 39,344
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 39,344
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 1,023
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 1,023
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 18,649
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 18,649
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 1,023
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 1,023
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 18,649
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 18,649
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 81
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 165
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 214
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 214
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 747
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 747
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 940
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 940
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,107
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,107
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 950
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 950
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 338
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 338
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,743
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,743
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 8,162
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 8,162
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 81
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 165
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 214
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 214
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 747
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 747
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 940
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 940
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,107
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,107
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 950
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 950
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 338
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 338
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,743
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,743
VMMC_CIRC By Age: 0-60 days 2017 5
VMMC_CIRC By Age: 10-14 2017 300
VMMC_CIRC By Age: 15-19 2017 225
VMMC_CIRC By Age: 2 months - 9 years 2017 23
VMMC_CIRC By Age: 20-24 2017 113
VMMC_CIRC By Age: 25-29 2017 45
VMMC_CIRC By Age: 30-49 2017 27
VMMC_CIRC By Age: 50+ 2017 13
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 751
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 751
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 723
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 651
Cross Cutting Budget Categories and Known Amounts Total: $110,000
Water $10,000
Gender: Gender Based Violence (GBV) $100,000
GBV Prevention